Skip to main content
Skip to content

Duplicate Document

This document appears to be a copy. The original version is:

EFTA Document EFTA01493457
Case File
efta-efta01493457DOJ Data Set 10Correspondence

EFTA Document EFTA01493457

Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01493457
Pages
0
Persons
0
Integrity
Loading PDF viewer...

Summary

Ask AI About This Document

0Share
PostReddit
Review This Document

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
FINANCIAL TRUST COMPANY INC ACCT. For the Period 9/1/12 to 9/30/12 Note P indicates position adjusted for Pending Trade Activity. Unrealized GainiLoss is shown as "N A" in cases where we do not have appropriate cost information for all lax lots comprising the position. Please contact your J P Morgan team for additional information. Equity Detail Pike Quantity Value Adjusted Tax Cost Unrealized Gain/Loss Est. Annual Inc Yield Original Cost Accrued Div. US Large Cap Equity ARIAD PHARMACEUTICALS INC 24.21 16,535.000 400,312.35 251,475.52 148,836.83 04033A-10-0 ARIA BIOGEN IDEC INC 149.21 2,095.000 312.594.95 250,454.95 62,140.00 09062X-10-3 BIIB FACEBOOK INC-A 21.66 17.500 003 379.050.00 665,000 00 (285,950.00) 30303M-10-2 FB Total US Large Cap Equity $1,091,967.30 31,166,930.47 (574.973.17) 30.00 0.00% US Small Cap Equity P PENNANTPARK INVESTMENT CORP 10 61 0.00 10.56% 708062-10-4 PNNT US Small/Mid Cap Equity P CASELLA WASTE SYSTEMS INC 4.27 0.00 CL A 147448-10-4 CWST JP Morgan Account Page 5 of 36 Consolidated Statement Page 9 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00016320 SONY GM_00285518 EFTA01493457

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.